1. Home
  2. MNSB vs LCTX Comparison

MNSB vs LCTX Comparison

Compare MNSB & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNSB
  • LCTX
  • Stock Information
  • Founded
  • MNSB 2003
  • LCTX 1990
  • Country
  • MNSB United States
  • LCTX United States
  • Employees
  • MNSB N/A
  • LCTX N/A
  • Industry
  • MNSB Major Banks
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MNSB Finance
  • LCTX Health Care
  • Exchange
  • MNSB Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • MNSB 133.8M
  • LCTX 110.2M
  • IPO Year
  • MNSB N/A
  • LCTX N/A
  • Fundamental
  • Price
  • MNSB $18.80
  • LCTX $0.55
  • Analyst Decision
  • MNSB
  • LCTX Strong Buy
  • Analyst Count
  • MNSB 0
  • LCTX 4
  • Target Price
  • MNSB N/A
  • LCTX $5.25
  • AVG Volume (30 Days)
  • MNSB 12.7K
  • LCTX 3.9M
  • Earning Date
  • MNSB 01-21-2025
  • LCTX 11-14-2024
  • Dividend Yield
  • MNSB 2.13%
  • LCTX N/A
  • EPS Growth
  • MNSB N/A
  • LCTX N/A
  • EPS
  • MNSB 1.21
  • LCTX N/A
  • Revenue
  • MNSB $62,730,000.00
  • LCTX $8,719,000.00
  • Revenue This Year
  • MNSB N/A
  • LCTX N/A
  • Revenue Next Year
  • MNSB $8.55
  • LCTX $123.52
  • P/E Ratio
  • MNSB $15.58
  • LCTX N/A
  • Revenue Growth
  • MNSB N/A
  • LCTX N/A
  • 52 Week Low
  • MNSB $14.97
  • LCTX $0.48
  • 52 Week High
  • MNSB $25.02
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • MNSB 49.16
  • LCTX 41.03
  • Support Level
  • MNSB $17.99
  • LCTX $0.48
  • Resistance Level
  • MNSB $20.88
  • LCTX $0.57
  • Average True Range (ATR)
  • MNSB 0.65
  • LCTX 0.05
  • MACD
  • MNSB -0.13
  • LCTX 0.01
  • Stochastic Oscillator
  • MNSB 28.03
  • LCTX 48.36

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: